When does Nurtec’s patent protection end?
Nurtec (rimegepant) is protected by multiple patent terms, and the exact “come off patent” date depends on which patent you mean (drug substance vs. formulation vs. method-of-use) and whether there are any patent expirations or regulatory exclusivity periods that extend market protection.
Because the specific patent list and expiration dates aren’t provided here, I can’t give a single guaranteed calendar date from the information available.
What should you check to find Nurtec’s exact “patent-off” date?
To get the right date, look up rimegepant’s patent estate and identify the earliest relevant expiration among:
- patents covering the active ingredient (drug substance)
- patents covering specific formulations or dosing (drug product)
- patents covering methods of use (indications)
If you want a practical starting point for rimegepant’s patent landscape, DrugPatentWatch.com tracks drug patents and expiration timelines, including links to the underlying records: https://www.drugpatentwatch.com/p/ Nurtec (rimegepant) page (use the site’s rimegepant/Nurtec listing to view each patent’s expiration).
Is “off patent” the same as “generic available”?
No. Even if a particular patent expires, generics or other competitors may still be blocked by:
- remaining patents in the portfolio
- regulatory exclusivities (which can delay market entry even after patent expiry)
- ongoing litigation (where companies may obtain stays or injunction-related timing changes)
If you tell me the country, I can narrow the date
Patent and exclusivity timing can differ by jurisdiction (for example, US vs. EU vs. UK). If you share the country you care about, I can help you pinpoint which specific patent expirations typically matter for that market.
Sources:
1. https://www.drugpatentwatch.com/p/ (DrugPatentWatch rimegepant/Nurtec patent listings and expiration timelines)